Triple-action weekly weight-loss drug reduces sleep apnea in two late-stage trials - Medical Xpress

Triple-action weekly weight-loss drug reduces sleep apnea in two late-stage trials Medical XpressThe Most Powerful Obesity Drug Yet Has a Hidden Benefit—and It Happens While You Sleep GizmodoRetatrutide Cuts Sleep Apnea Events in Phase III Trials EMJInvestigational Med Tied to Major Reduction in OSA Severity Medscapea new option to treat sleep apnea: weight-loss drugs BusinessWorld Online